SAN ANTONIO--(BUSINESS WIRE)--Evestra, Inc., today announces the signing of a collaboration partnership agreement with the Hungarian company, Gedeon Richter Plc. Under the terms of the agreement, Evestra will perform certain research and development activities on contraceptive products in exchange or licensing the commercialization rights for certain territories outside the U.S. to Gedeon Richter Plc.
The deal consists of upfront payments for research and early development funding, as well as clinical development, regulatory and sales performance milestones, and royalty payments on net sales.
In addition to its agreement with Gedeon Richter, Evestra will move its operations this month to the Texas Research Park in San Antonio, Texas. The new facilities include state-of-the-art chemistry laboratory space, which will enable Evestra to more fully and efficiently develop its product pipeline, including unmet medical needs in women’s health.
